About the Product

Description


Catabro Eye Drops contain Bromfenac, a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of inflammation and pain associated with eye conditions. It is commonly prescribed after cataract surgery to reduce inflammation and discomfort. Bromfenac works by inhibiting the production of prostaglandins, chemicals in the body responsible for pain and inflammation.

The medication is applied directly to the eye, where it provides targeted relief. It is designed for use in post-operative patients to reduce swelling and irritation following cataract surgery or other ophthalmic procedures. Catabro Eye Drops can also be used to manage inflammation related to other eye conditions, improving comfort and preventing complications.

This treatment is well-tolerated when used as prescribed, with minimal systemic absorption, making it suitable for localized therapy. It is essential to follow the recommended dosage instructions to ensure safety and efficacy.

Common side effects may include eye irritation, redness, burning, or a feeling of dryness. Rarely, it may cause blurred vision or allergic reactions.

Indicated for the treatment of inflammation and pain following cataract surgery.

For external use only. Discard the bottle after the prescribed course of treatment. Do not use if the solution is discolored or has particles.

Store at room temperature, between 20°C and 25°C. Keep tightly closed and protect from light. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Bromfenac 0.9 mg Eye Drops in the PCD pharma franchise market?

Bromfenac Eye Drops have strong demand in the ophthalmology (anti-inflammatory eye-care) segment, making them a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on post-surgical and inflammation-related eye treatments.

Why should medical distributors include Bromfenac Eye Drops in their product range?

Medical distributors and agencies can benefit from consistent demand for management of eye inflammation, post-cataract surgery pain, and ocular swelling. Bromfenac is a non-steroidal anti-inflammatory drug (NSAID) that reduces pain and inflammation in the eye This strengthens a reliable ophthalmology post-operative care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Bromfenac Eye Drops with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong ophthalmologist prescriptions, post-surgical demand (especially cataract cases), steady hospital usage, reliable supply chain support, and good margins in eye-care medicines.

How can I become a distributor or franchise partner for Bromfenac Eye Drops?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, territory rights, and distribution opportunities.